Daniel Herz-Roiphe

Daniel Herz-Roiphe currently serves as the Chief Operating Officer at Priovant Therapeutics, a position held since October 2021. Prior to this role, Daniel was the Chief Operating Officer and General Counsel at VantAI from October 2019 to October 2021 and held multiple roles at Roivant Sciences, including Executive Chair of Lokavant and VantAI, and Head of Legal for Roivant Health from January 2019 to September 2021. Legal experience includes a position as Legal Counsel (secondee) at Palantir Technologies, Associate at Kirkland & Ellis, and law clerk positions for Justice Stephen Breyer and Chief Judge Merrick Garland. Earlier experience includes work as a Summer Associate at Wachtell, Lipton, Rosen & Katz and as a Business Analyst at McKinsey & Company, along with an internship at the National Economic Council at The White House. Daniel holds a J.D. from Yale Law School and a B.A. from Harvard University.